ZACHARY YODER: Open Payments
NPI 1609639194 · LONDON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,847 in 156 payments from 13 companies in 2025. Trend: 2023 $18 · 2024 $737 · 2025 $2,847
Food & beverage: $2,692Education: $155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $721 |
| Janssen Biotech, Inc. | 35 | $664 |
| Novartis Pharmaceuticals Corporation | 19 | $404 |
| Amgen Inc. | 21 | $287 |
| UCB, Inc. | 15 | $209 |
| E.R. Squibb & Sons, L.L.C. | 10 | $162 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Lilly USA, LLC | 4 | $87 |
| GENZYME CORPORATION | 3 | $59 |
| Genentech USA, Inc. | 3 | $57 |
Products named: RINVOQ, TREMFYA, COSENTYX, Bimzelx, ORENCIA, TAVNEOS, SAPHNELO, SKYRIZI.
Industry payments across OH — which companies pay providers there.
